Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 397,664 | 683,287 | 278,820 | 129,630 | 84,685 |
| Marketable Securities | 1,494,711 | 1,816,257 | 1,805,252 | 893,085 | 580,538 |
| Receivables | 76,204 | 63,034 | 12,759 | 62,955 | 108,043 |
| Inventories | 21,965 | 18,180 | 8,582 | 9,982 | 7,489 |
| Other current assets | 140,163 | 139,839 | 102,473 | 73,082 | 17,177 |
| TOTAL | $2,130,707 | $2,720,597 | $2,207,886 | $1,168,734 | $797,932 |
| Non-Current Assets | |||||
| PPE Net | 181,077 | 153,651 | 132,160 | 121,907 | 92,845 |
| Intangibles | 27,937 | 25,674 | 24,032 | 22,004 | 20,365 |
| Other Non-Current Assets | 50,034 | 333,190 | 303,706 | 10,129 | 1,325 |
| TOTAL | $259,048 | $512,515 | $459,898 | $154,040 | $114,535 |
| Total Assets | $2,389,755 | $3,233,112 | $2,667,784 | $1,322,774 | $912,467 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 316,110 | 2,026 | 13,749 | 1,621 | 1,185 |
| Accounts payable and accrued liabilities | 17,199 | 16,067 | 28,660 | 24,886 | 21,120 |
| Accrued Expenses | 155,889 | 104,126 | 76,771 | 91,769 | 60,199 |
| TOTAL | $598,898 | $273,005 | $280,294 | $243,612 | $133,784 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,409 | 15,543 | 4,914 | 12,974 | 15,050 |
| Deferred Revenues | 108,376 | 118,272 | 160,256 | 125,336 | 51,280 |
| Other Non-Current Liabilities | 635,600 | 760,841 | 686,813 | 592,882 | 572,870 |
| TOTAL | $1,047,575 | $1,275,560 | $1,200,330 | $713,882 | $679,118 |
| Total Liabilities | $1,646,473 | $1,548,565 | $1,480,624 | $957,494 | $812,902 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 140,862 | 139,220 | 138,398 | 125,403 | 123,750 |
| Common Shares | 140 | 140 | 138 | 125 | 122 |
| Retained earnings | -1,131,306 | -707,534 | -967,293 | -1,241,034 | -1,181,428 |
| Other shareholders' equity | -21,071 | 188,163 | 107,065 | 52,508 | -30,358 |
| TOTAL | $743,282 | $1,684,547 | $1,187,160 | $365,280 | $99,565 |
| Total Liabilities And Equity | $2,389,755 | $3,233,112 | $2,667,784 | $1,322,774 | $912,467 |